The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 5.16

Cancer of the Cervix Uteri (Invasive)

Percent Distribution and Counts by Histology among Histologically Confirmed Cases, 2013-2017
Females by Race

Histologya All Races White Black Asian/
Pacific Islander
American Indian
/Alaska Nativeb
Hispanicc
Count Percent Count Percent Count Percent Count Percent Count Percent Count Percent
Carcinoma 21,852 97.6% 15,815 97.8% 3,286 96.2% 2,160 98.7% 157 98.1% 4,810 97.9%
Epidermoid carcinomad (8050-8131) 14,411 64.4% 10,089 62.4% 2,497 73.1% 1,427 65.2% 113 70.6% 3,233 65.8%
Squamous cell carcinoma (8070) 10,489 46.9% 7,319 45.3% 1,849 54.1% 1,029 47.0% 88 55.0% 2,241 45.6%
Squamous cell, keratinizing (8071) 1,448 6.5% 1,009 6.2% 282 8.3% 122 5.6% - - 350 7.1%
Squamous cell, non-keratinizing (8072) 1,796 8.0% 1,300 8.0% 255 7.5% 193 8.8% - - 478 9.7%
Squamous cell, Microinvasive (8076) 295 1.3% 206 1.3% 45 1.3% 28 1.3% - - 65 1.3%
Other (8050-8069, 8073-8075,8077-8131) 383 1.7% 255 1.6% 66 1.9% 55 2.5% - - 99 2.0%
Adenocarcinomae 6,464 28.9% 5,062 31.3% 611 17.9% 623 28.5% 39 24.4% 1,392 28.3%
Adenocarcinoma, NOS (8140) Adenosquamous (8560,8570) 3,262 14.6% 2,573 15.9% 295 8.6% 310 14.2% 16 10.0% 691 14.1%
694 3.1% 505 3.1% 91 2.7% 84 3.8% - - 181 3.7%
Other adenocarcinomasf 2,508 11.2% 1,984 12.3% 225 6.6% 229 10.5% 16 10.0% 520 10.6%
Other specific carcinomasg 471 2.1% 315 1.9% 91 2.7% 59 2.7% - - 82 1.7%
Unspecified, Carcinoma, NOS (8010-8011,8020-8022) 506 2.3% 349 2.2% 87 2.5% 51 2.3% - - 103 2.1%
Sarcomah 113 0.5% 73 0.5% 33 1.0% - - - - 21 0.4%
Other specific types (8720-8790,8930-8936, 8950-9030,9060-9110, 9260-9365,9380-9539) 255 1.1% 170 1.1% 61 1.8% 18 0.8% - - 37 0.8%
Unspecified (8000-8005) 162 0.7% 112 0.7% 37 1.1% - - - - 43 0.9%
Total 22,382 100.0% 16,170 100.0% 3,417 100.0% 2,188 100.0% 160 100.0% 4,911 100.0%

Footnotes:

Source: SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts). Percents may not sum to 100 due to rounding.

a Excludes Kaposi Sarcoma, mesothelioma, lymphomas, leukemias, myelomas, lymphoreticular, and immunoproliferative diseases.

b Estimates for American Indian/Alaska Native are based on the Purchased/Referred Care Delivery Area (PRCDA) counties.

c Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry.

d Epidermoid carcinoma includes squamous, basal, and transitional cell carcinomas.

e Adenocarcinoma includes histologies 8140-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8560,8570-8574,8576,8940-8941.

f Other adenocarcinomas include histologies 8141-8147,8160-8162,8180-8221,8250-8507,8514,8520-8551,8571-8574,8576,8940-8941.

g Other specific carcinomas include histologies 8012-8015,8030-8046,8150-8155,8170-8175,8230-8249,8508,8510-8513,8561-8562, 8575,8580-8671.

h Sarcoma includes histologies 8680-8713,8800-8921,9040-9044,9120-9136,9150-9252,9370-9373,9540-9582.

- Statistic not shown due to fewer than 16 cases during the time period.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.